trending Market Intelligence /marketintelligence/en/news-insights/trending/kzqjhlfmyhmrzzxtiqymfg2 content esgSubNav
In This List

Biolase secures additional time to regain compliance with Nasdaq listing rules

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Biolase secures additional time to regain compliance with Nasdaq listing rules

The Nasdaq granted Biolase Inc. an additional 180-days to regain compliance with the market's listing rules.

The California-based healthcare equipment company had received a noncompliance notice from Nasdaq in August 2017 for failing to meet the $1 minimum bid price requirement.